BioNTech SE (BNTX)
103.81
+1.86
(+1.83%)
USD |
NASDAQ |
Sep 02, 16:00
103.80
-0.01
(-0.01%)
After-Hours: 06:51
BioNTech Research and Development Expense (TTM) : 2.414B for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.414B |
| March 31, 2026 | 2.477B |
| December 31, 2025 | 2.379B |
| September 30, 2025 | 2.443B |
| June 30, 2025 | 2.387B |
| March 31, 2025 | 2.440B |
| December 31, 2024 | 2.437B |
| September 30, 2024 | 2.406B |
| June 30, 2024 | 2.343B |
| March 31, 2024 | 2.120B |
| December 31, 2023 | 1.928B |
| September 30, 2023 | 1.826B |
| Date | Value |
|---|---|
| June 30, 2023 | 1.629B |
| March 31, 2023 | 1.648B |
| December 31, 2022 | 1.610B |
| September 30, 2022 | 1.400B |
| June 30, 2022 | 1.363B |
| March 31, 2022 | 1.180B |
| December 31, 2021 | 1.120B |
| September 30, 2021 | 1.106B |
| June 30, 2021 | 1.056B |
| March 31, 2021 | 911.04M |
| December 31, 2020 | 714.56M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Moderna, Inc. | 2.635B |
| Biodexa Pharmaceuticals Plc | 5.234M |
| NuCana Plc | 12.59M |
| Mereo BioPharma Group Plc | 14.98M |
| MediGene AG | -- |